Fundamental Data for PHRM

Pharmion Corp is creating a global pharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients.

# Employees: 328

Address: 2525 28th Street Suite 200,Boulder,CO,USA

Phone: 720 564 9100

Fax: 720 564-9191

Website: www.pharmion.com

Email: IR@Pharmion.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Edward J. McKinley (Dir.)

Erle T. Mast (C.F.O.)

Judith A. Hemberger (Exec. V.P.; C.O.O.; Dir.)

Brian G. Atwood (Dir.)

Patrick J. Mahaffy (Presi.; C.E.O.; Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 12/31/2007

Next Earnings Date(Expected): 4/23/2008

Mean EPS (Next Qtr): ($0.31)

Mean EPS (Year): ($0.32)

Mean Estimate(Long Term): $27.35

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 2

Shares Performance

Period	PHRM	Compare to S&P
YTD	-0.01 %	30.61 %
4 Weeks	-0.01 %	-0.01 %
12 Weeks	-0.01 %	-0.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1305494

Shares Outstanding: 37M

Market Cap: ($0.01)M

52 Week High: $72.60

52 Week Low: ($0.01)

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 PHRM split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: -41.67 %

EPS Growth in Last Year: -64.52 %

Sales Growth in Last Quarter: 6.17 %

Sales Growth in Last Quarter: 19.01 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010